Swiss Life Asset Management Ltd Has $1.49 Million Stock Holdings in Astera Labs, Inc. $ALAB

Swiss Life Asset Management Ltd grew its holdings in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 48.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,978 shares of the company’s stock after buying an additional 2,926 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Astera Labs were worth $1,494,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in ALAB. Nordea Investment Management AB bought a new position in shares of Astera Labs in the fourth quarter valued at approximately $2,028,000. Geneva Partners LLC bought a new position in shares of Astera Labs in the third quarter valued at approximately $1,876,000. Numerai GP LLC raised its stake in shares of Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after acquiring an additional 7,992 shares during the last quarter. Handelsbanken Fonder AB raised its stake in shares of Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after acquiring an additional 93,800 shares during the last quarter. Finally, Paragon Advisors LLC bought a new position in shares of Astera Labs in the third quarter valued at approximately $1,829,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Stock Up 1.8%

Shares of ALAB opened at $232.68 on Friday. Astera Labs, Inc. has a 12-month low of $84.78 and a 12-month high of $262.90. The firm has a market capitalization of $39.88 billion, a PE ratio of 157.22, a price-to-earnings-growth ratio of 3.03 and a beta of 3.35. The stock’s fifty day simple moving average is $155.40 and its 200-day simple moving average is $156.41.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the firm posted $0.33 earnings per share. The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the completion of the sale, the chief executive officer directly owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $200.03, for a total transaction of $701,105.15. Following the sale, the director directly owned 63,639 shares of the company’s stock, valued at approximately $12,729,709.17. This trade represents a 5.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,497,338 shares of company stock valued at $236,827,957 over the last ninety days. Insiders own 12.50% of the company’s stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Northland Securities sharply raised its earnings outlook for Astera Labs (ALAB) across multiple periods, including FY2026, FY2027, and several quarterly estimates, signaling stronger expected profitability ahead.
  • Positive Sentiment: Analyst sentiment is also improving elsewhere, with another report lifting ALAB’s price target to $246.06, reinforcing the view that Wall Street sees more upside in the stock. Astera Labs price target increased by 20.85% to 246.06
  • Positive Sentiment: Zacks highlighted strong UALink 2.0 momentum and Scorpio switch expansion, saying these products are helping drive Astera Labs’ AI infrastructure growth and could support additional upside as deployments build into 2027. ALAB Benefits From Strong UALink Growth: More Upside Ahead?

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Barclays raised their target price on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. raised their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Morgan Stanley raised their target price on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Roth Mkm restated a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Finally, TD Cowen increased their price target on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $229.65.

Check Out Our Latest Analysis on ALAB

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.